Author:
Atmaca A,Al-Batran S-E,Maurer A,Neumann A,Heinzel T,Hentsch B,Schwarz S E,Hövelmann S,Göttlicher M,Knuth A,Jäger E
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, Romanski A, Kramer OH, Kampfmann M, Hoelzer D, Neubauer A, Ruthardt M, Ottmann OG (2005) Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukaemia. Cancer 104 (12): 2717–2725
2. Carducci MA, Gilbert J, Bowling MK, Noe D, Eisenberger MA, Sinibaldi V, Zabelina Y, Chen T, Grochow LB, Donehower RC (2001) A phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule. Clin Cancer Res 7: 3047–3055
3. Catalano MG, Fortunati N, Pugliese M, Costantino L, Poli R, Bosco O, Boccuzzi G (2005) Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab 90 (3): 1383–1389
4. Cress WD, Seto E (2000) Histone deactylases, transcriptional control, and cancer. J Cell Physiol 184: 1–16
5. Davie JR (1998) Covalent modifications of histones: expression from chromatin templates. Curr Opin Genet Dev 8: 173–178
Cited by
166 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献